Search research articles
Contact Us
Filters
Showing results (481-490 of 504) with videos related to
Page
of 51
Sort By:
The Journal of Urology
|
July 25, 2017
Prostate Specific Membrane Antigen Targeted <sup>18</sup>F-DCFPyL Positron Emission Tomography/Computerized Tomography for the Preoperative Staging of High Risk Prostate Cancer: Results of a Prospective, Phase II, Single Center Study
Michael A Gorin, Steven P Rowe, Hiten D Patel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 24, 2021
Diagnostic Performance of <sup>18</sup>F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study
Michael J Morris, Steven P Rowe, Michael A Gorin, et al.
The Prostate
|
January 12, 2023
Lack of repeatability of radiomic features derived from PET scans: Results from a <sup>18</sup> F-DCFPyL test-retest cohort
Rudolf A Werner, Bilêl Habacha, Susanne Lütje, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 20, 2021
Prospective, Single-Arm Trial Evaluating Changes in Uptake Patterns on Prostate-Specific Membrane Antigen-Targeted <sup>18</sup>F-DCFPyL PET/CT in Patients with Castration-Resistant Prostate Cancer Starting Abiraterone or Enzalutamide
Katherine A Zukotynski, Urban Emmenegger, Sebastien Hotte, et al.
BMC Cancer
|
July 1, 2017
A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE)
Noura Radwan, Ryan Phillips, Ashley Ross, et al.
The Journal of Urology
|
December 23, 2025
Performance of <sup>99m</sup>Tc-sestamibi SPECT/CT for Characterizing Renal Masses: Combined Results from a Prospective Scan-and-Resect Trial and Clinical Experience
Steven P Rowe, Salikh Murtazaliev, Alireza Amindarolzarbi, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
July 17, 2023
[<sup>18</sup>F]FNDP PET neuroimaging test-retest repeatability and whole-body dosimetry in humans
Yong Du, Jennifer M Coughlin, Alireza Amindarolzarbi, et al.
The Journal of Urology
|
April 9, 2026
Reply by Authors
Steven P Rowe, Salikh Murtazaliev, Alireza Amindarolzarbi, et al.
Molecular Imaging
|
March 14, 2022
High SUVs Have More Robust Repeatability in Patients with Metastatic Prostate Cancer: Results from a Prospective Test-Retest Cohort Imaged with <sup>18</sup>F-DCFPyL
Rudolf A Werner, Bilêl Habacha, Susanne Lütje, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 13, 2015
¹⁸F-DCFBC PET/CT for PSMA-Based Detection and Characterization of Primary Prostate Cancer
Steven P Rowe, Kenneth L Gage, Sheila F Faraj, et al.
Page
of 51
Search research articles
Search
Showing results (481-490 of 504) with videos related to
Sort By:
Page
of 51
The Journal of Urology
|
July 25, 2017
Prostate Specific Membrane Antigen Targeted <sup>18</sup>F-DCFPyL Positron Emission Tomography/Computerized Tomography for the Preoperative Staging of High Risk Prostate Cancer: Results of a Prospective, Phase II, Single Center Study
Michael A Gorin, Steven P Rowe, Hiten D Patel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 24, 2021
Diagnostic Performance of <sup>18</sup>F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study
Michael J Morris, Steven P Rowe, Michael A Gorin, et al.
The Prostate
|
January 12, 2023
Lack of repeatability of radiomic features derived from PET scans: Results from a <sup>18</sup> F-DCFPyL test-retest cohort
Rudolf A Werner, Bilêl Habacha, Susanne Lütje, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 20, 2021
Prospective, Single-Arm Trial Evaluating Changes in Uptake Patterns on Prostate-Specific Membrane Antigen-Targeted <sup>18</sup>F-DCFPyL PET/CT in Patients with Castration-Resistant Prostate Cancer Starting Abiraterone or Enzalutamide
Katherine A Zukotynski, Urban Emmenegger, Sebastien Hotte, et al.
BMC Cancer
|
July 1, 2017
A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE)
Noura Radwan, Ryan Phillips, Ashley Ross, et al.
The Journal of Urology
|
December 23, 2025
Performance of <sup>99m</sup>Tc-sestamibi SPECT/CT for Characterizing Renal Masses: Combined Results from a Prospective Scan-and-Resect Trial and Clinical Experience
Steven P Rowe, Salikh Murtazaliev, Alireza Amindarolzarbi, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
July 17, 2023
[<sup>18</sup>F]FNDP PET neuroimaging test-retest repeatability and whole-body dosimetry in humans
Yong Du, Jennifer M Coughlin, Alireza Amindarolzarbi, et al.
The Journal of Urology
|
April 9, 2026
Reply by Authors
Steven P Rowe, Salikh Murtazaliev, Alireza Amindarolzarbi, et al.
Molecular Imaging
|
March 14, 2022
High SUVs Have More Robust Repeatability in Patients with Metastatic Prostate Cancer: Results from a Prospective Test-Retest Cohort Imaged with <sup>18</sup>F-DCFPyL
Rudolf A Werner, Bilêl Habacha, Susanne Lütje, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 13, 2015
¹⁸F-DCFBC PET/CT for PSMA-Based Detection and Characterization of Primary Prostate Cancer
Steven P Rowe, Kenneth L Gage, Sheila F Faraj, et al.
Page
of 51